Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-108869
Filing Date
2025-08-14
Accepted
2025-08-14 16:10:50
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20250630.htm   iXBRL 10-Q 2786058
2 EX-10.1 annx-ex10_1.htm EX-10.1 32294
3 EX-31.1 annx-ex31_1.htm EX-31.1 17809
4 EX-31.2 annx-ex31_2.htm EX-31.2 17220
5 EX-32.1 annx-ex32_1.htm EX-32.1 15893
  Complete submission text file 0000950170-25-108869.txt   9092701

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT annx-20250630.xsd EX-101.SCH 1043949
64 EXTRACTED XBRL INSTANCE DOCUMENT annx-20250630_htm.xml XML 1590018
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 251219086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)